Press Release: Specialty Enzymes & Biotechnologies : New Clinical Trial on Safety and Efficacy of ImmunoSEB and ProbioSEB CSC3 Combination for Long-COVID Fatigue

CHINO, Calif., April 11, 2022 /PRNewswire/ -- Specialty Enzymes & Probiotics is proud to announce a clinical trial on the safety and efficacy of ImmunoSEB (systemic enzyme complex) and ProbioSEB CSC3 (a spore-forming probiotic blend) in people experiencing Long COVID, specifically...